Wrap Text
Abu Dhabi regulatory update
Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
(“Mediclinic”, the “Company” or the “Group”)
28 April 2017
Abu Dhabi regulatory update
Mediclinic International plc, the international private healthcare group, notes statements
made on 26 April 2017 by His Highness Sheikh Mohamed bin Zayed Al Nahyan, Crown Prince
of Abu Dhabi and Deputy Supreme Commander of the UAE Armed Forces. His Highness has
ordered the waiving of the 20% co-payment for holders of a Thiqa medical insurance card,
when receiving treatment at the private healthcare facilities in Abu Dhabi, with immediate
effect. The statements have been reported on the official news agency of the UAE (Wakalat
Anba'a al Emarat). The Group awaits to receive precise details of the changes from the Health
Authority Abu Dhabi (“HAAD”).
On 1 July 2016, HAAD introduced a 20% co-payment for Thiqa patients (those covered by
health insurance for UAE Nationals or others of similar status in Abu Dhabi) using private
healthcare facilities.
Mediclinic will continue to monitor the regulatory environment and the extent to which these
changes will affect the Middle East operating platform.
About Mediclinic International plc
Mediclinic is an international private healthcare group with operating platforms in Southern
Africa (South Africa and Namibia), Switzerland and the United Arab Emirates. Its core purpose
is to enhance the quality of life of patients by providing acute care, specialist-orientated,
multi-disciplinary healthcare services. Mediclinic also holds a 29.9% interest in Spire
Healthcare Group plc, a LSE listed and UK-based private healthcare group.
Mediclinic comprises 74 hospitals and 40 clinics. Mediclinic Southern Africa operates 49
hospitals and 2 day clinics throughout South Africa and 3 hospitals in Namibia with more than
8 000 inpatient beds in total; Hirslanden operates 16 private acute care facilities and 4 clinics
in Switzerland with more than 1 600 inpatient beds; and Mediclinic Middle East operates 6
hospitals and 34 clinics with more than 700 inpatient beds in the United Arab Emirates.
The platforms’ contributions to Group revenue for the financial year ended 31 March 2016
were 53.6% by Hirslanden, 30.8% by Mediclinic Southern Africa and 15.6% by Mediclinic
Middle East.
During February 2016, the combination of the Company (previously named Al Noor Hospitals
Group plc), with operations mainly in Abu Dhabi in the United Arab Emirates, and Mediclinic
International Limited was completed. Mediclinic International Limited was a South African
based international private healthcare group founded in 1983 and listed on the JSE, the South
African stock exchange, since 1986, with operations in South Africa, Namibia, Switzerland and
the United Arab Emirates (mainly in Dubai). The combination resulted in the renaming of the
enlarged group to Mediclinic International plc.
Mediclinic has a primary listing on the Main Market of the LSE, with secondary listings on the
JSE in South Africa and the NSX in Namibia.
For further information, please contact:
Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
+44 (0)20 3786 8181
Media queries
FTI Consulting
Brett Pollard/Debbie Scott (UK)
+44 (0)20 3727 1000
Frank Ford (South Africa)
+27 (0)21 487 9000
Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom
Website: www.mediclinic.com
Corporate broker: Morgan Stanley & Co International plc
JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
Date: 28/04/2017 07:05:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Sharenet Sites 
